Evidence Pack Catalog

Browse our library of AI-powered evidence packs spanning oncology, regulatory strategy, biomarker science, CMC quality, and competitive intelligence. Each pack delivers audit-ready deliverables backed by validated sources.

25 packs
ONC-001
Published

Oncology Trial Design Pack

Design smarter trials with real-world precedent data

Generates evidence-backed oncology trial design recommendations using historical protocol analysis, endpoint benchmarking, and regulatory precedent.

Oncology
35s3 sources
95
REG-001
Published

FDA IND Strategy Pack

File your IND right the first time

Assembles FDA IND filing precedents, module-level requirements, and common deficiency analysis to accelerate IND preparation and reduce clinical hold risk.

Regulatory Strategy
40s3 sources
93
ONC-002
Published

Dose Optimization Pack (Project Optimus)

Navigate the new dose optimization paradigm with confidence

Compiles FDA Project Optimus requirements, dose-finding trial precedents, and CDER review expectations to support oncology dose optimization strategies.

Oncology
30s3 sources
92
ONC-005
Published

Accelerated Approval Evidence Pack

Build a bulletproof accelerated approval submission

Compiles FDA accelerated approval precedents, surrogate endpoint acceptance history, and confirmatory trial requirements to support accelerated approval strategies.

Oncology
30s3 sources
90
REG-003
Published

Breakthrough/Fast Track Evidence Pack

Maximize your chances for expedited designation

Compiles FDA expedited program precedents, designation request strategies, and acceptance criteria analysis to support Breakthrough Therapy and Fast Track applications.

Regulatory Strategy
25s3 sources
89
ONC-003
Published

Biomarker-Driven Trial Design Pack

Turn molecular insights into registration-ready trial designs

Synthesizes FDA biomarker guidance, published biomarker-selected trial data, and diagnostic approval history to support biomarker-driven oncology development.

Oncology
40s3 sources
88
REG-004
Published

Pre-Submission Meeting Prep Pack

Walk into every FDA meeting fully prepared

Generates structured meeting briefing documents, question strategies, and precedent-based response preparation for FDA Type A, B, and C meetings.

Regulatory Strategy
30s3 sources
87
ONC-004
Published

Immuno-Oncology Combination Pack

Build the regulatory case for your IO combination

Aggregates IO trial data, FDA combination therapy guidance, and published IO combination outcomes to support immuno-oncology combination development strategies.

Oncology
35s3 sources
86
REG-002
Published

FDA/EMA Alignment Pack

Harmonize your global regulatory strategy

Maps FDA and EMA regulatory requirements side-by-side, identifies alignment opportunities, and flags divergent expectations to support global development planning.

Regulatory Strategy
45s3 sources
85
ONC-008
Published

Real-World Evidence Oncology Pack

Leverage real-world data for regulatory-grade evidence

Compiles FDA RWE framework guidance, RWD source evaluations, and published RWE submission precedents to support real-world evidence strategies in oncology.

Oncology
35s3 sources
82
CI-001
Published

Competitive Landscape Pack

Know every competitor before they know you

Maps the competitive landscape for your therapeutic area including pipeline assets, clinical trial activity, regulatory milestones, and strategic positioning analysis.

Competitive Intelligence
35s3 sources
80
ONC-006
Published

Oncology Safety Signal Pack

Anticipate safety signals before they derail your program

Analyzes FDA safety databases, REMS precedents, and post-marketing safety data to identify and contextualize potential oncology safety signals.

Oncology
25s3 sources
78
REG-005
Published

Global Regulatory Intelligence Pack

Track regulatory shifts across 40+ markets in real time

Monitors global regulatory changes, guideline updates, and policy shifts across major pharmaceutical markets to support proactive regulatory strategy adjustments.

Regulatory Strategy
20s3 sources
76
CI-003
Published

Market Access Evidence Pack

Build the value story payers need to hear

Compiles health economics data, payer landscape analysis, and reimbursement precedents to support market access strategy and value dossier development.

Competitive Intelligence
35s3 sources
75
BIO-001
Published

Biomarker Validation Pack

From candidate biomarker to qualified decision tool

Provides evidence frameworks for analytical validation, clinical validation, and regulatory qualification of biomarkers across therapeutic areas.

Biomarker & Translational
35s3 sources
74
BIO-004
Published

Companion Diagnostic Strategy Pack

Align your drug and diagnostic development timelines

Maps companion diagnostic co-development requirements, FDA PMA/510(k) precedents, and diagnostic partnering strategies for biomarker-driven programs.

Biomarker & Translational
30s3 sources
73
ONC-007
Published

Pediatric Oncology Strategy Pack

Navigate pediatric oncology requirements with regulatory clarity

Synthesizes RACE Act requirements, FDA pediatric study plans, and pediatric trial outcomes to support pediatric oncology development strategies.

Oncology
30s3 sources
72
BIO-003
Published

Target Validation Evidence Pack

Validate your target with multi-source evidence synthesis

Synthesizes genetic association data, functional genomics evidence, and clinical target validation precedents to build comprehensive target validation dossiers.

Biomarker & Translational
40s3 sources
71
REG-006
Published

Post-Approval Commitment Tracker Pack

Never miss a post-approval obligation deadline

Tracks and manages post-marketing requirements, commitments, and REMS obligations with precedent-based timelines and compliance monitoring.

Regulatory Strategy
20s3 sources
70
BIO-002
Published

PK/PD Modeling Intelligence Pack

Model-informed drug development backed by precedent

Aggregates pharmacokinetic/pharmacodynamic modeling precedents, FDA MIDD guidance, and published population PK analyses to support model-informed development strategies.

Biomarker & Translational
30s3 sources
68
CI-002
Published

Patent & Exclusivity Intelligence Pack

Map the IP landscape before it maps you

Analyzes patent landscapes, regulatory exclusivity timelines, and freedom-to-operate considerations for drug development programs.

Competitive Intelligence
30s3 sources
67
CMC-001
Published

Excipient Justification Pack

Justify every excipient with regulatory-grade evidence

Compiles excipient safety data, FDA Inactive Ingredient Database precedents, and formulation rationale evidence to support excipient justification in regulatory submissions.

CMC & Quality
20s3 sources
65
CMC-002
Published

Comparability Strategy Pack

Navigate manufacturing changes without derailing your program

Assembles FDA and ICH comparability guidance, precedent manufacturing change assessments, and analytical comparability study designs for post-change submissions.

CMC & Quality
30s3 sources
62
CMC-003
Published

Process Validation Narrative Pack

Build a validation narrative that reviewers trust

Generates process validation lifecycle narratives using FDA and ICH guidance, validation precedents, and statistical approaches for continued process verification.

CMC & Quality
25s3 sources
58
CMC-004
Published

Advanced Manufacturing Pack

Regulatory intelligence for next-generation manufacturing

Compiles FDA advanced manufacturing guidance, continuous manufacturing precedents, and emerging technology regulatory pathways for innovative manufacturing approaches.

CMC & Quality
30s3 sources
55

Showing 25 of 25 evidence packs